Carlsmed, Inc. (CARL) Stock Analysis & Investment Frameworks
Carlsmed, Inc. (CARL) stock analysis on Invetso. Review Carlsmed, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Carlsmed, Inc. Company Overview
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Medical - Healthcare Information Services
- Country: US
Carlsmed, Inc. Key Financial Metrics
- Market Cap: $418.28M
- Revenue: $50.51M
- ROE: -38.06%
- ROIC: -36.30%
- Dividend Yield: N/A
About Carlsmed, Inc.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.